Vaccine alliance says 300,000 doses of Merck's Ebola shot available for emergencies
Reuters Health News May 17, 2017
The GAVI global vaccine alliance said on Friday some 300,000 emergency doses of an Ebola vaccine developed by Merck could be available in case of a large–scale outbreak, after the World Health Organization confirmed a fatal case in Congo.
The vaccine, known as rVSV–ZEBOV, was shown to be highly protective against Ebola in clinical trials published last December.
A spokesman for the World Health Organization told Reuters on Friday that a person in the Democratic Republic of Congo had died after becoming infected with Ebola – a contagious virus that causes hemorrhagic fever.
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty -
Paid Market Research Surveys -
Case discussions, News & Journals' summaries
